Posted 1/22/2022 7:58 PM (GMT 0)
I was forced to switch from Remicade to Inflectra at my September infusion. I was livid that a medicine I had been on for 18 years, and was working well, could just be randomly switched by Cigna. I started having joint pain again, (which I had started experiencing about 8 years ago and it was managed very well by adjusting the dose of my Remicade) and blood tests confirmed my inflammation markers are through the roof. Just went to a rheumatologist a few days ago; he told me his patients were forced to switch from Remicade to Inflectra as well! So now I am having to see another specialist and take more meds because Cigna wanted to save a few bucks. So how does that really amount to any savings? Even though Remicade and Inflectra are biosimilars, they are not the same.
Anyone else having this issue? Thanks for listening to my rant.